Book Your Place
30 September 2025 12:00 - 13:00 CEST
Online
Members
€0.00
Turning groundbreaking biotech research into real-world solutions is often hindered by the infamous “valley of death” — the critical gap where funding is scarce, risk is high, and startups often fail to take shape. We will explore how the venture builder model can play a transformative role in bridging that gap and accelerating the path from lab bench to market.
In this session, we will discover:
- Why the valley of death is especially deep in biotech — and what it takes to cross it
- How venture builders provide the structure, resources, and expertise needed to de-risk academic IP
- Case studies of successful biotech startups launched from university research
- Practical strategies for TTOs to partner with venture builders and boost commercialization outcomes
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Booking Options
Testimonials
Perfect place to meet colleagues and share experiences on Technology Transfer.
Lidia Aguilera
University of Luxembourg, Luxembourg
Recent studies on both sides of the Atlantic, directed by either ASTP or AUTM, demonstrate the tremendous economic and societal benefit and value technology transfer has brought us.
Koenraad Debackere
KU Leuven, Belgium
The software training filled in the many blanks and brought my 'fractioned' knowledge in a structured way. Very useful!
Ilse Sienaert
KU Leuven R&D, Belgium
Exciting training, even after almost 10 hours I am curious about more experience and knowledge.
Petr Suchomel
Palacký University Olomouc, Czech Republic
Most relevant, interesting and practical training I have ever had, very interactive an multi-disciplinary. It makes an IMPACT.
Edith van Lishout
KU Leuven, Belgium
Subscribe to our newsletter
Join our newsletter and get the latest news